PABYX
Price
$15.48
Change
+$0.22 (+1.44%)
Updated
Apr 24 closing price
Net Assets
2.04B
RLBAX
Price
$33.37
Change
+$0.43 (+1.31%)
Updated
Apr 24 closing price
Net Assets
226.9B
Ad is loading...

PABYX vs RLBAX

Header iconPABYX vs RLBAX Comparison
Open Charts PABYX vs RLBAXBanner chart's image
Putnam Dynamic Asset Allocation Bal Y
Price$15.48
Change+$0.22 (+1.44%)
VolumeN/A
Net Assets2.04B
American Funds American Balanced R1
Price$33.37
Change+$0.43 (+1.31%)
VolumeN/A
Net Assets226.9B
PABYX vs RLBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PABYX vs. RLBAX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABYX is a Buy and RLBAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 227B vs. PABYX (2.04B). PABYX pays higher dividends than RLBAX: PABYX (2.96) vs RLBAX (1.27). PABYX was incepted earlier than RLBAX: PABYX (31 years) vs RLBAX (23 years). RLBAX (1.33) is less costly to investors than PABYX (0.68). PABYX is a more actively managed with annual turnover of: 222.00 vs. RLBAX (171.00). PABYX has a lower initial minimum investment than RLBAX: PABYX (0) vs RLBAX (250). RLBAX annual gain was more profitable for investors over the last year : 3.37 vs. PABYX (-1.19). RLBAX return over 5 years is better than : 31.54 vs. PABYX (21.75).
PABYXRLBAXPABYX / RLBAX
Total Expense Ratio0.681.3351%
Annual Report Gross Expense Ratio0.681.3351%
Fund Existence31 years23 years-
Gain YTD-3.119-1.759177%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.04B227B1%
Annual Yield % from dividends2.961.27232%
Returns for 1 year-1.193.37-35%
Returns for 3 years6.9112.4356%
Returns for 5 years21.7531.5469%
Returns for 10 years20.4041.0350%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLSI10.440.59
+5.99%
Greenwich LifeSciences
SBFM1.550.08
+5.44%
Sunshine Biopharma Inc
NBIX105.762.54
+2.46%
Neurocrine Biosciences
HIW28.290.21
+0.75%
Highwoods Properties
HFWA22.990.01
+0.04%
Heritage Financial Corp